Press Releases


Media Contact:
Stephen Majors
Head of Global Communications
smajors@alliancerm.org


Media Contact:
Stephen Majors
Head of Global Communications
smajors@alliancerm.org

ARM welcomes the release of the Center for Medicare and Medicaid Innovation’s (CMMI) Cell and Gene Therapy Access Model

January 31, 2024

Washington, DC

The voluntary model recognizes that transformative, durable, and potentially curative gene therapies require innovative thinking about access, payment, and healthcare delivery.


FDA Approves First Gene Therapies for Sickle Cell Disease, Including First-Ever CRISPR Gene-Editing Therapy

December 8, 2023

Washington, DC

Today, the FDA approved two gene therapies to treat sickle cell disease, marking the biggest day in the history of gene therapy and a seminal moment in the history of biotechnology and human health.


New Analysis by Tufts’ NEWDIGS Shows that Durable Cell and Gene Therapies Have Substantially Higher Clinical Success Rates than Other Treatments

October 11, 2023

Carlsbad, CA

New analysis shows that durable cell and gene therapies have clinical success rates between two and three times higher than other types of treatments.


The Alliance for Regenerative Medicine Announces Election of 2024 Board of Directors

October 10, 2023

Carlsbad, CA

The Alliance for Regenerative Medicine (ARM), the leading international advocacy organization championing the benefits of engineered cell therapies and genetic medicines, today announced the election of its 2024 Board of Directors.